Speakers - DEWC2025

Biography

I graduated from Edinburgh University with a BSc in Biological Science, Business Studies, and Metropolitan College, Slough, Diploma in Marketing. My Clinical Pathology career started by selling Diagnostic Tests and Blood Group reagents to Hospital Laboratories and Research Laboratories in Scotland and Northern England then focused on Endocrinology with GD Searle Diagnostic Pathology Service in the UK, Italy, the Middle East and Africa. Visits to many countries enhanced knowledge of medical and diagnostic hospital services for patients and research. A brief experience in Histology and Tissue Culture Laboratory and Autoradiography technique.  Approached by Picker International when MRI Magnetic Resonance Imaging and Spectroscopy led to involvement with the original clinical use of MRI scanning in Neurology, Orthopaedics Musculoskeletal and Cardiac Imaging with experience with the researchers when MRI was launched. Setting up and managing involvement with Europe’s First Mobile MRI Shared Service to NHS and Private Hospitals in England with a team of enthusiastic Radiographers anxious to ensure excellent MRI Imaging for patient MRI Diagnosis was challenging and rewarding.  This experience led to involvement in assessing the suitability of the Excimer Ophthalmic Laser procedure to treat Astigmatism and Short Sight Ophthalmology.  Illness led to a career change into Diabetes and Endocrinology involving Blood Glucose Monitoring with a link to the IDDF in 1997 at a Conference in Helsinki, Finland. This path after serious acute Hypoglycaemia with Neuroglycopenia and PTSD injury after the prescription of the wrong Insulin and Dose to treat T1D Diabetes opened the Hypoglycaemia Research door ongoing now with several peer-reviewed publications explaining the experience and Forensic Legal Aspects of Hypoglycaemia. The incorporation of ACS Aston Clinton Scientific Ltd with DRI-FT Diabetes Research Information Facts for Treatment extended this research while at the same time introducing Multi sonic Silent Operating Schill Nebuliser Medical Device to deliver Inhaled Prostacyclin Therapy for patients suffering Pulmonary Hypertension, Asthma, COPD, Cystic Fibrosis. In 2020 COVID-19 led to life-changing change until Vaccines were developed.  A Diabetes Patient's Journey through COVID and beyond has led us in 2025 to identify what may have gone wrong with loss of life but opportunity with a sound foundation to ‘Make a Difference’ for Future Generations.